LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX

被引:2
作者
Chupp, Geoffrey L.
Lugogo, Njira L.
Wechsler, Michael E.
Lawson, Kaitlyn
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher
机构
关键词
D O I
10.1016/j.chest.2023.07.075
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:9A / 14A
页数:6
相关论文
共 50 条
[21]   Efficacy Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Specific Perennial Allergen Immunoglobulin E Thresholds [J].
Lindsley, Andrew ;
Colice, Gene ;
Martin, Neil ;
Spahn, Joseph ;
Martin, Nicole ;
Ambrose, Chris ;
Hoyte, Flavia .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) :AB18-AB18
[22]   EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND ALLERGIC RHINITIS GROUPED BY BASELINE BLOOD EOSINOPHIL COUNT: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR [J].
Wechsler, Michael E. ;
Chupp, Geoffrey L. ;
Israel, Elliot ;
Castro, Mario ;
Bober, Magdalena ;
Lindsley, Andrew ;
Spahn, Joe D. ;
Ambrose, Christopher S. .
CHEST, 2024, 166 (04) :4664A-4680A
[23]   Population Pharmacokinetic Modeling and Exposure-Efficacy and Body Weight-Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma [J].
Zheng, Yanan ;
Abuqayyas, Lubna ;
Quartino, Angelica ;
Guan, Ye ;
Gao, Yuying ;
Liu, Lu ;
Hellqvist, Asa ;
Colice, Gene ;
Macdonald, Alexander .
JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (08) :908-921
[24]   Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials [J].
Trudo, F. ;
Hirsch, I. ;
Gopalan, G. ;
Martin, U. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[25]   Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study [J].
Kraft, M. ;
Chupp, G. L. ;
Reeh, K. ;
Lindsley, A. W. ;
Cook, B. ;
Hunter, G. ;
Ambrose, C. S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[26]   Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma [J].
Corren, Jonathan ;
Wechsler, Michael E. ;
Chupp, Geoffrey ;
Roseti, Stephanie L. ;
Hellqvist, Asa ;
Martin, Neil ;
Llanos, Jean -Pierre ;
Ambrose, Christopher S. ;
Colice, Gene .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (03) :943-+
[27]   Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study [J].
Carr, Tara F. ;
Moore, Wendy C. ;
Kraft, Monica ;
Brusselle, Guy ;
Castro, Mario ;
Chupp, Geoffrey L. ;
Wechsler, Michael E. ;
Hunter, Gillian ;
Lindsley, Andrew W. ;
Llanos, Jean-Pierre ;
Burke, Luke K. ;
Chandarana, Shradha ;
Ambrose, Christopher S. .
ADVANCES IN THERAPY, 2024, 41 (07) :2978-2990
[28]   Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma [J].
Tat, Tugba Songul ;
Cilli, Aykut .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) :546-549
[29]   Tezepelumab can restore normal lung function in patients with severe, uncontrolled asthma [J].
Pavord, Ian Douglas ;
Brightling, Christopher E. ;
Korn, Stephanie ;
Martin, Nicole ;
Ponnarambil, Sandhia ;
Molfino, Nestor A. ;
Parnes, Jane R. ;
Cook, Bill ;
Ambrose, Christopher S. .
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[30]   Long-Term Safety and Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma [J].
Albers, Frank C. ;
Lugogo, Njira ;
Gilson, Martyn J. ;
Price, Robert ;
Yancey, StevenW. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) :AB14-AB14